Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial
Authors:
- H CelisHCH Celis
- L ThijsLTL Thijs
- Ja StaessenJSJa Staessen
- Wh BirkenhägerWBWh Birkenhäger
- Cj BulpittCBCj Bulpitt
- Pw de LeeuwPLPw de Leeuw
- G LeonettiGLG Leonetti
- C NachevCNC Nachev
- J TuomilehtoJTJ Tuomilehto
- Rh FagardRFRh Fagard
- the Syst-Eur investigatorsTIthe Syst-Eur investigators
- 1 September 2001
- journal article
- clinical trial
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 15 (9) , 613-618
Abstract
OBJECTIVE: To assess the relationship between chronic intake of nonsteroidal anti-inflammatory drugs (NSAID) and outcome, in particular (gastrointestinal) bleeding and to investigate whether the effect of chronic NSAID intake was similar in untreated and treated elderly hypertensives. METHODS: Eligible patients (> or = 60 years, with systolic blood pressure 160-219 mm Hg and diastolic blood pressure < 95 mm Hg) were randomised to active treatment or placebo. Active treatment consisted of nitrendipine, with the possible addition of enalapril, hydrochlorothiazide, or both, titrated or combined to reduce the sitting systolic blood pressure by at least 20 mm Hg to below 150 mm Hg. Patients never taking NSAIDs (n = 2882) were compared with patients on chronic NSAID intake (n = 861), defined as reporting NSAID intake on at least 50% of the patient forms. RESULTS: There was a tendency towards lower mortality (relative hazard rate (95% confidence interval (CI), 0.77 (0.56-1.06)) and higher incidence of bleeding (1.13 (0.63-2.05) with chronic NSAID intake. Although there was no significant interaction between calcium-channel blocker (CCB)-based treatment and chronic NSAID intake for any of the end points, chronic NSAID intake tended to be associated with a lower incidence of bleeding on active treatment as compared to placebo (P-value of the interaction term = 0.07). CONCLUSION: The effect of chronic NSAID intake on outcome was similar in patients on active treatment based on a dihydropyridine CCB or on placebo. However, chronic NSAID intake might have a less deleterious effect on bleeding on active treatment as compared to placebo.status: publisheKeywords
This publication has 25 references indexed in Scilit:
- Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugsGut, 2000
- Secondary Stroke Prevention with Low-Dose Aspirin, Sustained Release Dipyridamole Alone and in CombinationThrombosis Research, 1998
- Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugsGut, 1997
- Nimodipine Neuroprotection in Cardiac Valve ReplacementStroke, 1996
- Inhibitory effect of clentiazem (TA-3090) on platelet aggregation -alone and in combination with aspirin or ticlopidineThrombosis Research, 1994
- Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- ASPIRIN WITH AN ADRENERGIC OR A CALCIUM-CHANNEL-BLOCKING AGENT AS NEW COMBINATION THERAPY FOR ARTERIAL THROMBOSISThe Lancet, 1985
- Antithrombogenic effects of calcium channel blockers: Synergism with prostacyclin and thromboxane synthase inhibitorsThrombosis Research, 1984
- DRUG-INDUCED GASTROINTESTINAL BLEEDINGThe Lancet, 1978